KY-05009 is a chemical compound that effectively suppresses TGF-beta1-induced epithelial-to-mesenchymal transition (EMT) in human lung adenocarcinoma cells, reduces TNIK protein expression and the transcriptional activity of Wnt target genes, and promotes apoptosis in cancer cells, displaying anti-cancer properties. Furthermore, it functions as an ATP-competitive Traf2- and Nck-interacting kinase (TNIK) inhibitor with a Ki of 100 nM.
Molekulargewicht:
352.41
Reinheit:
98.06%
CAS Nummer:
[1228280-29-2]
Formel:
C18H16N4O2S
Target-Kategorie:
MAPK|||Apoptosis|||Wnt/beta-catenin
T11793
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten